Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
RXC004 – Clinical Phase 1 study ongoing
Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
Lead fibrosis programme – Pan-ROCK inhibitor for fibrosis related to IBD
